Comparison of Platelet Rich Plasma and Alternative Therapies for the Treatment of Tennis Elbow (Lateral Epicondylitis)



Status:Active, not recruiting
Conditions:Orthopedic
Therapuetic Areas:Orthopedics / Podiatry
Healthy:No
Age Range:18 - Any
Updated:11/23/2017
Start Date:August 2012
End Date:September 2018

Use our guide to learn which trials are right for you!

Impact of Platelet Rich Plasma Over Alternative Therapies in Patients With Lateral Epicondylitis

"Tennis elbow" is the most common cause of lateral elbow pain, generally caused by either
work or sports related repetitive strain. In this condition, a tendon along the outside of
the elbow becomes inflamed leading to pain, especially with flexing and extending the elbow.

Many treatments have been attempted, including physiotherapy and steroids, with little
success. One treatment which has been very effective is the injection of the patients own
blood (taken from their other non-affected arm) into their abnormal tendon. The blood
recruits the patients own healing factors and heals the damaged tendon. As platelets are
thought to be largely responsible, injection of concentrated platelets, extracted from the
patient's blood (platelet rich plasma) is a newer, but expensive, technique.

At this point, it is unclear whether whole blood, concentrated platelets, or simply passing a
ultrasound-guided needle through the abnormal tendon as a means to stimulate tissue healing
(tendon fenestration) is the better treatment.

The objective of this trial is to compare platelet rich plasma, whole blood, dry needle
tendon fenestration, and sham injection (with physical therapy) to identify the best and most
cost-effective therapy for this debilitating condition.


Inclusion Criteria:

- Adult man or woman aged 18 years or greater.

- Clinical diagnosis of lateral epicondylitis based on site of pain, pain elicited with
active extension of the wrist in pronation and elbow extension.

- Documented sonographic diagnosis of common extensor tendinosis based on tendon
thickening, areas of hypoechogenicity, and loss of the normal echotexture.

- Chronic symptoms (equal or greater than 3 months).

- Pain of at least 5 out of 10 on a visual analog scale (VAS).

- Provision of informed consent.

Exclusion Criteria:

- Acute symptom onset (less than 2 months).

- History of acute elbow trauma (less than one week).

- History of rheumatoid arthritis.

- History of malignancy.

- Pregnancy

- Patients requiring anti-platelet medication for the treatment of heart attack, stroke
or other medical condition.

- Previous surgery for lateral epicondylitis.

- Previous local injections, including steroids within the past 6 months.

- Signs of other causes for lateral elbow pain (posterior interosseous nerve entrapment,
osteochondral lesion).
We found this trial at
2
sites
Hamilton, Ontario
Principal Investigator: Mary M Chiavaras, MD, PhD
Phone: 905-527-4322
?
mi
from
Hamilton,
Click here to add this to my saved trials
500 S State St
Ann Arbor, Michigan 48109
(734) 764-1817
University of Michigan The University of Michigan was founded in 1817 as one of the...
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials